Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Premenstrual Syndrome Treatment Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
the reproductive-age population
- Improved diagnostic tools, including hormone tests and symptom-tracking apps
- Increasing demand for non-invasive and over-the-counter treatments
- Growing integration of telemedicine services for accessible care
- Limited awareness in low-income and rural regions
- High cost of advanced hormonal therapies and branded medications
- Potential side effects associated with certain treatments
- Growing acceptance of natural and herbal remedies in mainstream healthcare
- Development of personalized and targeted therapies for PMS management
- Adoption of digital health platforms for symptom tracking and personalized care
- Increasing popularity of herbal supplements like chasteberry and magnesium
- Introduction
- Prescription
- OTC
- Introduction
- Single Nutritional Supplements
- Vitamins
- Minerals
- Herbal Supplements
- Others
- Combined Nutritional Supplements
- Introduction
- Analgesics
- Antidepressant
- Pain Relievers
- Oral Contraceptives
- Others
- Introduction
- Online Sales Channel
- Direct Sales Channel
- Pharmacies / Drug Stores
- Other Channels
- Introduction
- North America Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Canada
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size &ay Distribution Channel (USD Million)
- US
- Europe Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Germany
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Italy
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million) l (USD Million)
- Spain
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Europe
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- UK
- Asia Pacific (APAC) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Miannel (USD Million)
- Japan
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- India
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USDecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Middle East & Africa (MEA) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Type (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Compali>Emerging Players
- Innovative Players
- Key Players and their Competitive Positioning
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- China
- Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Herbalife International of America, Inc.
- Pharmavite LLC
- Natures Bounty
- Amway
- GNC Holdings, Inc.
- USANA Health Sciences, Inc.
- GlaxoSmithKline Plc
- RBK Nutraceuticals Pty Ltd.
- Archer Daniels Midland
- Power Gummies
- Looni
- Other Prominent Players
Note: *Indicative list
**For li